Pages that link to "Q48329991"
Jump to navigation
Jump to search
The following pages link to Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma (Q48329991):
Displaying 50 items.
- DNA methylation age of human tissues and cell types (Q21183994) (← links)
- Endogenous mammalian histone H3.3 exhibits chromatin-related functions during development (Q21198852) (← links)
- Epigenetic pathways and glioblastoma treatment (Q24273294) (← links)
- Combined MYC and P53 defects emerge at medulloblastoma relapse and define rapidly progressive, therapeutically targetable disease (Q24310764) (← links)
- ZMYND11 links histone H3.3K36me3 to transcription elongation and tumour suppression (Q24338606) (← links)
- Reduced H3K27me3 and DNA hypomethylation are major drivers of gene expression in K27M mutant pediatric high-grade gliomas (Q24339074) (← links)
- DNA repair mechanisms and their clinical impact in glioblastoma (Q26740256) (← links)
- ROS and Brain Gliomas: An Overview of Potential and Innovative Therapeutic Strategies (Q26747496) (← links)
- Molecular Biology in Pediatric High-Grade Glioma: Impact on Prognosis and Treatment (Q26785952) (← links)
- Chromatin Dynamics in Vivo: A Game of Musical Chairs (Q26799305) (← links)
- Pre-Clinical Models of Diffuse Intrinsic Pontine Glioma (Q26799976) (← links)
- Pathology, Molecular Genetics, and Epigenetics of Diffuse Intrinsic Pontine Glioma (Q26801528) (← links)
- In vivo models of brain tumors: roles of genetically engineered mouse models in understanding tumor biology and use in preclinical studies (Q26820289) (← links)
- Biomarkers for glioma immunotherapy: the next generation (Q26825496) (← links)
- Spinal cord tumours: advances in genetics and their implications for treatment (Q26851596) (← links)
- Molecular characteristics of pediatric high-grade gliomas (Q26860786) (← links)
- Epigenetic dysregulation: a novel pathway of oncogenesis in pediatric brain tumors (Q26864920) (← links)
- Histone H3 mutations--a special role for H3.3 in tumorigenesis? (Q26865965) (← links)
- IDH1/2 mutations target a key hallmark of cancer by deregulating cellular metabolism in glioma (Q26995506) (← links)
- Modern brain tumor imaging (Q27002344) (← links)
- Oligodendroglioma: pathology, molecular mechanisms and markers (Q27002448) (← links)
- Training stem cells for treatment of malignant brain tumors (Q27006790) (← links)
- Developing epigenetic diagnostics and therapeutics for brain disorders (Q27022987) (← links)
- Chromatin signatures of cancer (Q27024162) (← links)
- Neuronal Activity Promotes Glioma Growth through Neuroligin-3 Secretion (Q27322798) (← links)
- The double PHD finger domain of MOZ/MYST3 induces -helical structure of the histone H3 tail to facilitate acetylation and methylation sampling and modification (Q27680427) (← links)
- DNA methylation changes in epithelial ovarian cancer histotypes (Q27690722) (← links)
- ATRX loss refines the classification of anaplastic gliomas and identifies a subgroup of IDH mutant astrocytic tumors with better prognosis (Q27852494) (← links)
- Accelerating glioblastoma drug discovery: Convergence of patient-derived models, genome editing and phenotypic screening (Q28080068) (← links)
- Diverse involvement of EZH2 in cancer epigenetics (Q28084911) (← links)
- Emerging technologies for studying DNA methylation for the molecular diagnosis of cancer (Q28087759) (← links)
- The somatic genomic landscape of glioblastoma (Q28300185) (← links)
- Relation between Established Glioma Risk Variants and DNA Methylation in the Tumor (Q28392499) (← links)
- Pre-Clinical Study of Panobinostat in Xenograft and Genetically Engineered Murine Diffuse Intrinsic Pontine Glioma Models (Q28468398) (← links)
- Histone variant H3.3 maintains a decondensed chromatin state essential for mouse preimplantation development (Q28507170) (← links)
- A high-throughput in vitro drug screen in a genetically engineered mouse model of diffuse intrinsic pontine glioma identifies BMS-754807 as a promising therapeutic agent (Q28543923) (← links)
- Contribution of the two genes encoding histone variant h3.3 to viability and fertility in mice (Q28591185) (← links)
- A histone H3K9M mutation traps histone methyltransferase Clr4 to prevent heterochromatin spreading (Q28829593) (← links)
- Functionally defined therapeutic targets in diffuse intrinsic pontine glioma (Q28833173) (← links)
- Overcoming therapeutic resistance in glioblastoma: the way forward (Q29248396) (← links)
- Diffuse Intrinsic Pontine Glioma: New Pathophysiological Insights and Emerging Therapeutic Targets (Q30251385) (← links)
- Neuro-oncology: Five new things (Q30415098) (← links)
- Transcription factors FOXG1 and Groucho/TLE promote glioblastoma growth (Q30575960) (← links)
- Long-term survival (>13 years) in a child with recurrent diffuse pontine gliosarcoma: a case report (Q30679553) (← links)
- Similarity network fusion for aggregating data types on a genomic scale (Q30742291) (← links)
- Glioblastoma multiforme: exploratory radiogenomic analysis by using quantitative image features (Q30820677) (← links)
- Assessing CpG island methylator phenotype, 1p/19q codeletion, and MGMT promoter methylation from epigenome-wide data in the biomarker cohort of the NOA-04 trial (Q30836702) (← links)
- Treatment of glioblastoma in elderly patients. (Q30838145) (← links)
- Advances in the management of paediatric high-grade glioma (Q30870633) (← links)
- Complex heatmaps reveal patterns and correlations in multidimensional genomic data. (Q31098875) (← links)